🇺🇸 Influenza in United States

Influenza (Influenza and COVID-19 Combination B) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Pricing & reimbursement

Influenza in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is Influenza approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Influenza in United States?

BioNTech is the originator. The local marketing authorisation holder may differ — check the official source linked above.

What does Influenza cost in United States?

annual_list: USD 80000.00 per year. Final patient cost depends on reimbursement and any patient access scheme.